Literature DB >> 20186098

Trends and determinant factors in hypertension control in a population study with 25 years of follow-up.

Ulla O Andersen1, Gorm B Jensen.   

Abstract

OBJECTIVE: The present study focused on trend in hypertension control and on determinant factors that may influence efficacy in antihypertensive therapy. Two measures of treatment efficacy were used: population blood pressure and the relative frequency of effectively treated patients (blood pressure <140/90 mmHg). DESIGN AND METHODS: Copenhagen City Heart Study is a prospective longitudinal epidemiological study with 25 years of follow-up. The study population were treated hypertensive patients. The blood pressure measurement was fully standardized and measurement method was unchanged throughout the observation period. A questionnaire was completed by the participants and double-checked by the technicians.
RESULTS: The number of treated hypertensive patients increased considerably and hypertension control increased from 21 to 26%. Pretreatment SBP was stable in the observation period indicating that start-to-treat practice was stable. Treated SBP decreased from 157.9 to 148.7 mmHg. Four determinant factors were significant. Men presented a higher pretreatment SBP before starting antihypertensive medication. Elderly patients presented a higher pretreatment SBP and were poorly treated as compared with younger hypertensive patients. Obesity was associated with a high threshold SBP. The fourth factor was diagnosis. Patients with myocardial infarction were better treated in last surveys than patients from other diagnosis groups. Treated DBP was stable.
CONCLUSION: Hypertension treatment efficacy is improving but still far from acceptable. The evaluation of determinant factors identified four areas that need special attention: men, elderly and obese hypertensive patients. The fourth factor is diagnosis. The results may indicate a beneficial effect of systematic control of hypertensive patients during a limited time after a myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186098     DOI: 10.1097/HJH.0b013e328335fa81

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Arterial stiffness is associated with increase in blood pressure over time in treated hypertensives.

Authors:  Thais Coutinho; Kent R Bailey; Stephen T Turner; Iftikhar J Kullo
Journal:  J Am Soc Hypertens       Date:  2014-04-04

Review 2.  Contributions of risk factors and medical care to cardiovascular mortality trends.

Authors:  Majid Ezzati; Ziad Obermeyer; Ioanna Tzoulaki; Bongani M Mayosi; Paul Elliott; David A Leon
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

3.  Long term trends in control of hypertension in the Northern Sweden MONICA study 1986-2009.

Authors:  Ellinor Törmä; Bo Carlberg; Marie Eriksson; Jan-Håkan Jansson; Mats Eliasson
Journal:  BMC Public Health       Date:  2015-09-24       Impact factor: 3.295

4.  Self-reported knowledge and awareness about blood pressure and hypertension: a cross-sectional study of a random sample of men and women aged 60-74 years.

Authors:  Ina Qvist; Marie D Thomsen; Jes S Lindholt; Hans Ibsen; Jeroen Ml Hendriks; Lars Frost
Journal:  Clin Epidemiol       Date:  2014-02-15       Impact factor: 4.790

5.  Impact of ethnic-specific guidelines for anti-hypertensive prescribing in primary care in England: a longitudinal study.

Authors:  Lena Barrera; Craig Leaper; Utz J Pape; Azeem Majeed; Marta Blangiardo; Christopher Millett
Journal:  BMC Health Serv Res       Date:  2014-02-25       Impact factor: 2.655

6.  Proximal correlates of metabolic phenotypes during 'at-risk' and 'case' stages of the metabolic disease continuum.

Authors:  M T Haren; G Misan; J F Grant; J D Buckley; P R C Howe; A W Taylor; J Newbury; R A McDermott
Journal:  Nutr Diabetes       Date:  2012-01-16       Impact factor: 5.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.